Variants from Clinical Pharmacogenetics Implementation Consortium

Minimum submission review status:		Collection method:
Minimum conflict level: Report conflict between different conditions
Gene type: Distinguish antisense genes from sense genes
Show significances as they were submitted (without aggregation into standard terms)
		ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic	likely pathogenic	uncertain significance	likely benign	benign	drug response	total
0	0	0	0	0	629	629

Gene and significance breakdown #

Total genes and gene combinations: 2

Download table as spreadsheet

Gene or gene combination	drug response	total
CYP2C19	434	434
CYP2C19, LOC110599570	195	195

Condition and significance breakdown #

Total conditions: 10

Download table as spreadsheet

Condition	drug response	total
Citalopram response	595	595
Escitalopram response	595	595
Sertraline response	595	595
Voriconazole response	595	595
Clopidogrel response	55	55
CYP2C19: no function	11	11
CYP2C19: uncertain function	10	10
CYP2C19: decreased function	6	6
CYP2C19: normal function	6	6
CYP2C19: increased function	1	1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.